SCHEMBL4906229

SCHEMBL4906229

CCN(c1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 3/20 0.58
HDAC3 O15379 2/20 0.58
HDAC11 Q96DB2 2/20 0.58
HDAC6 Q9UBN7 2/20 0.58
LCK P06239 5/20 0.50
LMNA P02545 4/20 0.50
BTK Q06187 4/20 0.50
MAPK14 Q16539 2/20 0.50
ABL1 P00519 1/20 0.50
KIT P10721 1/20 0.50
SRC P12931 1/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MAPT P10636 3/20 0.49
CASP6 P55212 1/20 0.49
CSF1R P07333 1/20 0.49
BRAF P15056 1/20 0.49
KDR P35968 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905443 0.92 HDAC8 (0.56) HDAC8HDAC3HDAC11HDAC6LMNA
SCHEMBL4902866 0.91 HDAC8 (0.56) HDAC8HDAC3HDAC11HDAC6LCK
SCHEMBL4904215 0.85 MEN1 (0.61) HDAC8HDAC3HDAC11HDAC6LMNA
SCHEMBL4906199 0.84 LMNA (0.51) LMNAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL4906350 0.83 LMNA (0.55) HDAC8HDAC3HDAC11HDAC6LMNA
SCHEMBL4905920 0.83 HDAC8 (0.54) HDAC8HDAC3HDAC11HDAC6LMNA
SCHEMBL4904061 0.81 SERPINE1 (0.50) HDAC8HDAC3HDAC11HDAC6LMNA
SCHEMBL4903714 0.81 LMNA (0.56) HDAC8HDAC3HDAC11HDAC6LMNA
SCHEMBL2501251 0.80 LCK (0.72) LCKLMNABTKMAPK14ABL1
SCHEMBL4904134 0.79 LMNA (0.54) HDAC8HDAC3HDAC11HDAC6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HDAC8 882/4885HDAC3 157/4885HDAC11 657/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HDAC8 882/4885HDAC3 157/4885HDAC11 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.